Established in 2003, DiagnOptics is the pioneer and inventor of cutting edge diagnostic devices that can non-invasively diagnose and assess the risk of diabetes and its complications. Its technological advance in detecting fluorescence of Advanced Glycation Endproducts (AGEs) has led to the invention of the AGE Reader™ - a state of art diagnostic device which can determine the tissue accumulation of AGEs in 30 seconds.
Specialties
Non-invasive diabetes screening, Non-invasive cardiovascular risk assessment, Medical Technology
